Artifacts and pitfalls in myocardial perfusion imaging

Journal of Nuclear Medicine Technology

Volumn 34, Issue 4, 2006, Pages 193-211

  Burrell, Steven ^a,b   MacDonald, Anita ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Artifacts; Cardiac imaging; Myocardial perfusion imaging; SPECT

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; THALLIUM 201;

CARDIOVASCULAR DISEASE; DEXTROCARDIA; DIAGNOSTIC IMAGING; ERROR; HEART LEFT BUNDLE BRANCH BLOCK; HEART MOVEMENT; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MYOCARDIAL PERFUSION IMAGING; PATIENT ASSESSMENT; PROGNOSIS; QUALITY CONTROL; REVIEW; ARTIFACT; CLINICAL PRACTICE; DIAGNOSTIC ERROR; HEART LEFT VENTRICLE FUNCTION; IMAGE ENHANCEMENT; METHODOLOGY; MOVEMENT (PHYSIOLOGY); PERFUSION; PRACTICE GUIDELINE; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ARTIFACTS; DIAGNOSTIC ERRORS; HUMANS; IMAGE ENHANCEMENT; MOVEMENT; PERFUSION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 35148815597     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Zaret BL. Nuclear cardiology: a victim of its own success [abstract]. J Nucl Cardiol. 2002;9:451-452.
2. Strauss HW, Miller DD, Wittry MD, et al. Society of Nuclear Medicine Procedure Guideline for Myocardial Perfusion Imaging. Version 3.0, approved June 15, 2002.
3. Klocke FJ, chair. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Available at: http://www.acc.org/qualityandscience/clinical/topic/ topic.htm#cardiacimaging. Accessed November 3, 2006.
4. Lapeyre AC 3rd, Goraya TY, Johnston DL, Gibbons RJ. The impact of caffeine on vasodilator stress perfusion studies. J Nucl Cardiol. 2004;11:506-511.
5. Gibbons RJ, chair. ACC/AHA Guidelines for Exercise Testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol. 1997;30(1):260-311.
6. Williams KA, Hill KA, Sheridan CM. Noncardiac findings on dual-isotope myocardial perfusion SPECT. J Nucl Cardiol. 2003;10:395-402.
7. Abdel-Dayem HM. Current tumor imaging agents. In: Aktolun C, Tauxe WN, eds. Nuclear Oncology. Berlin, Germany: Springer-Verlag; 1999:401-414.
8. Cooper JA, Neumann PH, McCandless BK. Effect of patient motion on tomographic myocardial perfusion imaging. J Nucl Med. 1992;33:1566-1571.
9. Wheat JM, Currie GM. Impact of patient motion on myocardial perfusion SPECT diagnostic integrity: Part 2. J Nucl Med Technol. 2004;32:158-163.
10. Sorrell V, Figueroa B, Hansen CL. The "hurricane sign": evidence of patient motion artifact on cardiac single-photon emission computed tomographic imaging. J Nucl Cardiol. 1996;3:86-88.
11. Germano G. Technical aspects of myocardial SPECT imaging. J Nucl Med. 2001;42:1499-1507.
12. Paul AK, Nabi HA. Gated myocardial perfusion SPECT: basic principles, technical aspects, and clinical applications. J Nucl Med Technol. 2004;32:179-187.
13. Olson WH, Schmincke DR, Henley BL. Time and frequency dependence of disposable ECG electrode-skin impedance. Med Instrum. 1979;13:269-272.
14. Nichols K, Dorbala S, DePuey EG, Yao S-S, Sharma A, Rozanski A. Influence of arrhythmias on gated SPECT myocardial perfusion and function quantification. J Nucl Med. 1999;40:924-934.
15. Nichols K, Yao S-S, Kamran M, Faber TL, Cooke CD, DePuey EG. Clinical impact of arrhythmias on gated SPECT cardiac myocardial perfusion and function assessment. J Nucl Cardiol. 2001;8:19-30.
16. Groch MW, Erwin WD. Single-photon emission computed tomography in the year 2001: instrumentation and quality control. J Nucl Med Technol. 2001;29:12-18.
17. Hines H, Kayayan R, Colsher J, et al. National Electrical Manufacturers Association recommendations for implementing SPECT instrumentation quality control. J Nucl Med Technol. 1999;27:67-72.
18. Chen J, Caputlu-Wilson SF, Shi H, et al. Automated quality control of emission-transmission misalignment for attenuation correction in myocardial perfusion imaging with SPECT-CT systems. J Nucl Cardiol. 2006;13:43-49.
19. DePuey EG, Garcia EV, eds. American Society of Nuclear Cardiology: updated imaging guidelines for nuclear cardiology procedures - Part 1. J Nucl Cardiol. 2001;8:G1-G58.
20. Corbett JR, Ficaro EP. Clinical review of attenuation-corrected cardiac SPECT. J Nucl Cardiol. 1999;6:54-68.
21. Miles J, Cullom SJ, Case JA. An introduction to attenuation correction. J Nucl Cardiol. 1999;6:449-457.
22. Heller GV, Links J, Bateman TM, et al. American Society of Nuclear Cardiology/Society of Nuclear Medicine joint position statement: attenuation correction of myocardial perfusion SPECT scintigraphy. J Nucl Cardiol. 2004;11:229-230.
23. Cherry S, Sorenson JA, Phelps ME. Tomographic reconstruction in nuclear medicine. In: Cherry S, Sorenson JA, Phelps ME. Physics in Nuclear Medicine. 3rd ed. Philadelphia, PA: W.B. Saunders; 2003:273-298.
24. Germano G, Chua T, Kiat H, Areeda JS, Berman DS. A quantitative phantom analysis of artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med. 1994;35:356-359.
25. van Dongen AJ, van Rijk PP. Minimizing liver, bowel, and gastric activity in myocardial perfusion SPECT. J Nucl Med. 2000;41:1315-1317.
26. Hurwitz GA, Clark EM, Slomka PJ, Siddiq SK. Investigation of measures to reduce interfering abdominal activity on rest myocardial images with Tc-99m sestamibi. Clin Nucl Med. 1993;18:735-741.
27. Stowers SA, Umfrid R. Supine-prone SPECT myocardial perfusion imaging: the poor man's attenuation compensation [letter]. J Nucl Cardiol. 2003;10:338.
28. Segall GM, Davis MJ. Prone versus supine thallium myocardial SPECT: a method to decrease artifactual inferior defects. J Nucl Med. 1989;30:548-555.
29. Thomas GS, Prill NV, Majmundar H, et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol. 2000;7:439-446.
30. Vitola JV, Brambatti JC, Caliqaris F, et al. Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity, and increases heart-to-liver activity ratio on Tc-99m sestamibi imaging. J Nucl Cardiol. 2001;8:652-659.
31. Hansen CL. The conundrum of left bundle branch block. J Nucl Cardiol. 2004;11:90-92.
32. Burns RJ, Galligan L, Wright LM, Lawand S, Burke RJ, Gladstone PJ. Improved specificity of myocardial thallium-201 single-photon emission computed tomography in patients with left bundle branch block by dipyridamole. Am J Cardiol. 1991;68:504-508.
33. Wynne J, Braunwald E. The cardiomyopathies and cyocarditides. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia, PA: W.B. Saunders; 2001:1751-1806.
34. Wackers FJT, Soufer R, Zaret BL. Nuclear cardiology. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia, PA: W.B. Saunders; 2001:273-323.
35. Udelson JE, Leppo JA. Single photon myocardial perfusion imaging and exercise radionuclide angiography in the detection of coronary artery disease. In: Murray IPC, Ell PJ, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. Vol. 2. New York, NY: Churchill Livingstone Inc.; 1994:1129-1156. J Nucl Med Technol 2006; 34:215-219